6 Park Road, Rawdon, Leeds LS19 6HX (tel: 07939 922 712)
|
|
|---|
To assess the preferences of people attending a substance misuse facility towards the treatment options available for opiate dependency. Interviews were conducted using a card sorting technique.
RESULTS
The majority (60%) of the 101 participants believed that detoxification was superior to maintenance in preventing illicit heroin use. The preferred treatment options were oral methadone, buprenorphine, drug-free rehabilitation, in-patient detoxification and prescription of injectable drugs.
CLINICAL IMPLICATIONS
Both pharmacological and psychosocial options, including in-patient detoxification and rehabilitation, are among the treatments preferred by clients of substance misuse services. There is also a significant demand for both injectable drugs and dihydrocodeine.
|
|
|---|
There is limited evidence supporting the notion that involving service users leads to more accessible, better-quality services (Beresford & Croft, 1993; Baker et al, 1997; Crawford et al, 2002; Simpson & House, 2002). However, there is no consensus on how best to engage patients in health service planning (McIver, 1991; Baker et al, 1997; Kelson, 1997). The National Service Framework for Mental Health created a working group to develop research tools with service users to assess their views on how services can best meet their needs (Department of Health, 2000b). There are some reports of the perceptions of programme directors and clients regarding the effectiveness of methadone treatment (Mavis et al, 1991). However, there is no substantial report in the medical literature of the treatment preferences of the users of addiction services. The objective of this study was to assess the preference of people with opiate dependency attending a substance misuse facility for the various treatment options.
|
|
|---|
A modified Q-sort technique was used to obtain patient preferences (Block, 1978; Yalom, 1985). Participants were given cards stating 17 treatment options (Table 1) with the instruction: Please place these treatments in order from the one that you think is most likely to stop you using street heroin to the one that you think is least helpful (intravenous and oral methadone were presented as separate options and were both available from the service providers). The participants then placed the cards in order on a table, with the treatments they rated highest furthest away and those ranked lowest nearest to them. The order of preference was recorded. If patients did not recognise a particular treatment or had no views on preference these options were not rated and the cards were placed in a separate pile. Two cards referred to fictitious drugs (Hypnazone and Superval) to act as tests of reliability. The participants were then asked to remove from their preference list treatments that they had never experienced. The order of preference for treatments that the person had actualy received was then recorded in the same manner. The orders of preferences were compared by giving oral methadone an arbitrary score of 20. Other preferences were ranked in relation to this. Finally, patients were asked: Do you think out-patient detoxification or maintenance is most likely to stop you using street heroin? (detoxification was defined as the dose of drug prescriptions is reduced gradually over 3-6 months and maintenance was defined as drug prescriptions for as long as you want it).
|
View this table: [in a new window] | Table 1. Preference rankings of 15 different treatment options |
Participants gave written informed consent. Approval to undertake the study was obtained from the South London and Maudsley NHS Trust research ethics committee.
|
|
|---|
The top preferences in the participants initial ranking included both pharmacological and psychosocial options. Preferences for oral methadone, buprenorphine, drug-free rehabilitation (for 6-18 months) and in-patient detoxification (over 2-4 weeks) were each reported by a majority of participants (Table 1). Preferences for treatments that the participants had personally experienced also comprised both pharmacological and psychosocial options (Table 2). Whereas all participants had experienced oral methadone treatment, fewer than half had direct exerience of many of the other treatment options.
|
View this table: [in a new window] | Table 2. Preference rankings of treatments that participants had personally experienced |
|
|
|---|
The top four preferences - oral methadone, buprenorphine, rehabilitation and detoxification - are recognised by purchasers as treatment priorities (National Treatment Agency for Substance Misuse, 2002a). The next three preferences, however, were more controversial treatments: intravenous methadone, oral dihydrocodeine and i.v. diamorphine. The use of injectables in the treatment of substance misuse has always been the subject of controversy, and dihydrocodeine is not licensed for use in opiate dependence (Department of Health, 1999b; Home Office, 2000). There is Government support for the use of prescribed injectables, but services will probably be reluctant to provide them (National Treatment Agency for Substance Misuse, 2002b; Luty, 2003).
No evidence was found to support the view that participants previous experience of treatment might influence their perception of effectiveness. Prescribed injectables were ranked lower in Table 2 than in Table 1, suggesting that injectables were less desirable in practice than clients might imagine; however, further analysis of the results from Table 1 showed no difference in preferences for treatment between those who had been prescribed injectables and those who had not. It was notable that both benzodiazepines and dihydrocodeine were apparently rated more highly by those who had experienced treatment with these agents (Table 2) than the overall preferences reported in Table 1. This apparent preference arose because a greater proportion of participants had used these drugs than had experienced rehabilitation or detoxification, and disappeared when the results were analysed separately for participants who had direct experience of rehabilitation and detoxification. Finally, the responses were analysed separately for participants who had experienced three or more forms of treatment (including at least one non-drug therapy). The results were very similar to the ranking in Table 2, with no treatment changing its position by more than one place.
Drug-free rehabilitation and in-patient detoxification were rated highly among the preferences. It was also notable that two-thirds of participants believed that detoxification was better than maintenance therapy. This is particularly encouraging, as it indicates that treatment-seeking participants were motivated to overcome their dependence on both prescribed and illicit drugs. It is perhaps regrettable that evidence shows maintenance is probably superior to detoxification in preventing illicit opiate use (National Consensus Development Panel, 1998).
Strengths and limitations of the study
The list of treatments was restricted to eight pharmacological and seven
psychosocial treatments, to avoid presenting participants with an unmanageable
number of options (combining the options from each group would lead to 56
permutations). Nevertheless, they were still presented with a substantial
number of choices (17 including the fictitious drugs). Participants were asked
to distinguish between detoxification and maintenance treatments.
Unfortunately the study could not determine the preferred combination of other
drugs, regimens and psychosocial support, and this could be the subject of
further research.
The people in this study were very similar to patients notified in 2000-2001 to English regional drug misuse databases, and other research samples, in terms of age, gender, ethnicity and socio-demographic status (Gossop et al, 1995; Government Statistical Office, 2000). Nevertheless, they were people with opiate dependency seeking treatment from a teaching hospital substance misuse facility with a harm reduction rather than an abstinence philosophy, which is likely to attract patients with similar preferences. The results may not be typical of other community samples.
Two fictious agents (Hypnazone and Superval) were included in the treatment preference lists to ensure that participants understood the procedure. All but six patients correctly identified and excluded these options from their preferences. However, another limitation of the study is the reliance on self-report of preferences to a clinician employed at the treatment centre, raising the possibility that patients would report preferences that they imagined the researcher would approve of, rather than expressing genuine opinions.
In conclusion, the results suggest that both pharmacological and psychosocial treatments are desirable options for people seeking treatment of their opiate dependency. These options include in-patient detoxification and rehabilitation. There is also a significant demand for both injectable drugs and dihydrocodeine.
|
|
|---|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||